124 related articles for article (PubMed ID: 38685112)
1. Correction: TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2.
Fan Y; Chen S; Chu C; Yin X; Jin J; Zhang L; Yan H; Cao Z; Liu R; Xin M; Li L; Yin C
J Ovarian Res; 2024 Apr; 17(1):93. PubMed ID: 38685112
[No Abstract] [Full Text] [Related]
2. TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2.
Fan Y; Chen S; Chu C; Yin X; Jin J; Zhang L; Yan H; Cao Z; Liu R; Xin M; Li L; Yin C
J Ovarian Res; 2024 Mar; 17(1):67. PubMed ID: 38528613
[TBL] [Abstract][Full Text] [Related]
3. TP63-truncating variants cause isolated premature ovarian insufficiency.
Tucker EJ; Jaillard S; Grover SR; van den Bergen J; Robevska G; Bell KM; Sadedin S; Hanna C; Dulon J; Touraine P; Sinclair AH
Hum Mutat; 2019 Jul; 40(7):886-892. PubMed ID: 30924587
[TBL] [Abstract][Full Text] [Related]
4. A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency.
Li L; Wang B; Zhang W; Chen B; Luo M; Wang J; Wang X; Cao Y; Kee K
Hum Reprod; 2017 Jan; 32(1):248-255. PubMed ID: 27836978
[TBL] [Abstract][Full Text] [Related]
5. Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency.
Tucker EJ; Gutfreund N; Belaud-Rotureau MA; Gilot D; Brun T; Kline BL; Bell KM; Domin-Bernhard M; Théard C; Touraine P; Robevska G; van van den Bergen J; Ayers KL; Sinclair AH; Dötsch V; Jaillard S
Hum Mutat; 2022 Oct; 43(10):1443-1453. PubMed ID: 35801529
[TBL] [Abstract][Full Text] [Related]
6. Novel phenotype of syndromic premature ovarian insufficiency associated with TP63 molecular defect.
Mathorne SW; Ravn P; Hansen D; Beck-Nielsen SS; Gjørup H; Sørensen KP; Fagerberg CR
Clin Genet; 2020 May; 97(5):779-784. PubMed ID: 32067224
[TBL] [Abstract][Full Text] [Related]
7. TP63 gain-of-function mutations cause premature ovarian insufficiency by inducing oocyte apoptosis.
Huang C; Zhao S; Yang Y; Guo T; Ke H; Mi X; Qin Y; Chen ZJ; Zhao S
J Clin Invest; 2023 Mar; 133(5):. PubMed ID: 36856110
[TBL] [Abstract][Full Text] [Related]
8. CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion.
Sasaki Y; Koyama R; Maruyama R; Hirano T; Tamura M; Sugisaka J; Suzuki H; Idogawa M; Shinomura Y; Tokino T
Cancer Biol Ther; 2012 Dec; 13(14):1512-21. PubMed ID: 22990203
[TBL] [Abstract][Full Text] [Related]
9. CLCA2: A Potential Guardian against Premature Senescence and Skin Aging.
Guerrero-Navarro L; Martic I; Ploner C; Jansen-Dürr P; Cavinato M
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540205
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency.
Vanderschelden RK; Rodriguez-Escriba M; Chan SH; Berman AJ; Rajkovic A; Yatsenko SA
J Assist Reprod Genet; 2023 Sep; 40(9):2211-2218. PubMed ID: 37453019
[TBL] [Abstract][Full Text] [Related]
11. Analysis of NR5A1 in 142 patients with premature ovarian insufficiency, diminished ovarian reserve, or unexplained infertility.
Jaillard S; Sreenivasan R; Beaumont M; Robevska G; Dubourg C; Knarston IM; Akloul L; van den Bergen J; Odent S; Croft B; Jouve G; Grover SR; Duros S; Pimentel C; Belaud-Rotureau MA; Ayers KL; Ravel C; Tucker EJ; Sinclair AH
Maturitas; 2020 Jan; 131():78-86. PubMed ID: 31787151
[TBL] [Abstract][Full Text] [Related]
12. A newly identified missense mutation in CLCA2 is associated with autosomal dominant cardiac conduction block.
Mao Z; Wang Y; Peng H; He F; Zhu L; Huang H; Huang X; Lu X; Tan X
Gene; 2019 Sep; 714():143990. PubMed ID: 31326550
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis.
Shao T; Xue Y; Fang M
Front Cell Dev Biol; 2021; 9():771466. PubMed ID: 34869368
[TBL] [Abstract][Full Text] [Related]
14. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
[TBL] [Abstract][Full Text] [Related]
15. CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.
Ramena G; Yin Y; Yu Y; Walia V; Elble RC
PLoS One; 2016; 11(3):e0147489. PubMed ID: 26930581
[TBL] [Abstract][Full Text] [Related]
16. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer.
Li X; Cowell JK; Sossey-Alaoui K
Oncogene; 2004 Feb; 23(7):1474-80. PubMed ID: 14973555
[TBL] [Abstract][Full Text] [Related]
17. CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways.
Xin W; Zhang J; Zhang H; Ma X; Zhang Y; Li Y; Wang F
BMC Mol Cell Biol; 2022 Oct; 23(1):44. PubMed ID: 36280802
[TBL] [Abstract][Full Text] [Related]
18. Transport of CLCA2 to the nucleus by extracellular vesicles controls keratinocyte survival and migration.
Seltmann K; Hettich B; Abele S; Gurri S; Mantella V; Leroux JC; Werner S
J Extracell Vesicles; 2024 Apr; 13(4):e12430. PubMed ID: 38602325
[TBL] [Abstract][Full Text] [Related]
19. How polymorphic markers contribute to genetic diseases in different populations? The study of inhibin A for premature ovarian insufficiency.
Christofolini DM; Cordts EB; Santos-Pinheiro F; Kayaki EA; Dornas MCF; Santos MC; Bianco B; Barbosa CP
Einstein (Sao Paulo); 2017; 15(3):269-272. PubMed ID: 29091146
[TBL] [Abstract][Full Text] [Related]
20. High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.
Bestetti I; Castronovo C; Sironi A; Caslini C; Sala C; Rossetti R; Crippa M; Ferrari I; Pistocchi A; Toniolo D; Persani L; Marozzi A; Finelli P
Hum Reprod; 2019 Mar; 34(3):574-583. PubMed ID: 30689869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]